MedPath

UNIVERSITY OF WASHINGTON

UNIVERSITY OF WASHINGTON logo
🇺🇸United States
Ownership
Private
Established
1861-01-01
Employees
10K
Market Cap
-
Website
https://www.cs.washington.edu

Efficacy of Early Stage Alzheimer's Support Groups

Not Applicable
Completed
Conditions
Memory Loss
Alzheimer's Disease
Dementia
Interventions
Behavioral: Educational Seminar
Behavioral: Early Stage Memory Loss Support Group
First Posted Date
2006-10-24
Last Posted Date
2014-01-10
Lead Sponsor
University of Washington
Target Recruit Count
154
Registration Number
NCT00391794
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

Induction of Mild Hypothermia Following Out-of-hospital Cardiac Arrest

Phase 2
Completed
Conditions
Out-of-hospital Cardiac Arrest
Interventions
Other: Rapid infusion of 2 liters of 4oC normal saline
Drug: Rapid infusion of cold normal saline
First Posted Date
2006-10-24
Last Posted Date
2014-12-02
Lead Sponsor
University of Washington
Target Recruit Count
1359
Registration Number
NCT00391469
Locations
🇺🇸

Harborview Medical Center, Seattle, Washington, United States

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

Phase 3
Completed
Conditions
HIV Infection
Herpes Simplex
Sexually Transmitted Diseases
Interventions
Drug: matching placebo
First Posted Date
2006-09-21
Last Posted Date
2013-08-22
Lead Sponsor
University of Washington
Target Recruit Count
20
Registration Number
NCT00378976
Locations
🇵🇪

Asociacion Civil Impacta Salud y Educacion, Lima, Peru

Real-Time Support for Exercise Persistence in COPD

Phase 1
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
COPD
Emphysema
Chronic Bronchitis
Interventions
Behavioral: Coached exercise persistence intervention
Behavioral: Self-Monitored exercise persistence intervention
First Posted Date
2006-09-08
Last Posted Date
2009-12-07
Lead Sponsor
University of Washington
Target Recruit Count
17
Registration Number
NCT00373932
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

A Trial of Point of Care Information in Ambulatory Pediatrics

Phase 3
Completed
Conditions
Pharyngitis
Urticaria
Allergic Rhinitis
Acute Otitis Media
Sinusitis
Croup
Constipation
Bronchiolitis
First Posted Date
2006-08-29
Last Posted Date
2006-08-29
Lead Sponsor
University of Washington
Target Recruit Count
44
Registration Number
NCT00368823
Locations
🇺🇸

Roosevelt Pediatric Clinic, Seattle, Washington, United States

🇺🇸

Skagit Valley Pediatrics, Skagit Valley, Washington, United States

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

Completed
Conditions
Breast Cancer
Interventions
Other: laboratory biomarker analysis
Procedure: needle biopsy
Procedure: positron emission tomography
Procedure: radionuclide imaging
Radiation: fludeoxyglucose F 18
First Posted Date
2006-08-15
Last Posted Date
2016-12-28
Lead Sponsor
University of Washington
Target Recruit Count
42
Registration Number
NCT00362973
Locations
🇺🇸

Seattle Cancer Care Alliance, Seattle, Washington, United States

🇺🇸

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome

Not Applicable
Completed
Conditions
Metabolic Syndrome X
Dyslipidemias
Interventions
Behavioral: Moderate Fat and Moderate Carbohydrate Diet
Behavioral: Low Fat and High Carbohydrate Diet
First Posted Date
2006-08-15
Last Posted Date
2010-10-28
Lead Sponsor
University of Washington
Target Recruit Count
71
Registration Number
NCT00362908
Locations
🇺🇸

Northwest Lipid Research Clinic, Seattle, Washington, United States

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Not Applicable
Completed
Conditions
Breast Cancer
First Posted Date
2006-08-15
Last Posted Date
2017-04-05
Lead Sponsor
University of Washington
Target Recruit Count
56
Registration Number
NCT00363012
Locations
🇺🇸

Tumor Vaccine Group at the University of Washington, Seattle, Washington, United States

🇺🇸

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Phase 4
Completed
Conditions
Genital Herpes
Interventions
First Posted Date
2006-08-09
Last Posted Date
2021-11-18
Lead Sponsor
University of Washington
Target Recruit Count
31
Registration Number
NCT00362297
Locations
🇺🇸

University of Washington Virology Research Clinic, Seattle, Washington, United States

Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease

Phase 4
Withdrawn
Conditions
Giant Lymph Node Hyperplasia
Interventions
First Posted Date
2006-08-09
Last Posted Date
2017-04-18
Lead Sponsor
University of Washington
Registration Number
NCT00361933
© Copyright 2025. All Rights Reserved by MedPath